Skip to content
Research Article Open access CC BY 4.0

Prevalence of HIV and Hepatitis B Infections among Children in Bayelsa State, Nigeria

Helen Ifeoma Udujih, Moses Opuama, Chizaram Winners Ndubueze

International STD Research & Reviews · pp. 33–40 · Published 29 Aug 2024

10.9734/ISRR/2024/v13i2177

Abstract

The prevalence of HBV infection amongst HIV-positive and HIV-negative children was assessed. A total of 322 study samples were collected from discarded residual blood spot samples following routine diagnosis of HIV in children. Statistical differences in the prevalence of HBV between the HIV-positive and HIV-negative samples were calculated using the Pearson chi-square test, and a p-value < 0.05 was considered statistically significant. The number of HBV-positive children was 33, giving a prevalence of 10.25%, while the number of HBV-negative children was 289, giving a prevalence of 89.75%. The prevalence of HIV serotype-I was significantly higher in the HBV-positive children (15.96%) than the HBV-negative children (84.04%). The prevalence of HIV serotype II was also significantly higher in the HBV-positive children (8.96%) than the HBV-negative children (91.04%). The prevalence of HIV and HBV co-infection was higher in the female (7.78%) than the male (5.16%). The highest prevalence of HIV and HBV c-infection with respect to age was seen in children within the age range of 1 – 2 years (8.57%), while the lowest prevalence was seen in children between the age range of 3 – 4 years (0%). The finding of a 10.25 % HBV prevalence in this children cohort is clinically significant. The non-statistically significant difference in HBV prevalence between HIV-positive and HIV-negative children suggests that the high prevalence of HBV infection in children may be independent of HIV infection. Therefore, the transmissions of HBV and HIV in children are not closely linked.

Paediatrics transmission HIV/AIDS hepatitis HBsAg

References (27)

  1. 1 Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C [DOI]
  2. 2 Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case‐control study [DOI]
  3. 3 Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus–Infected Subjects [DOI]
  4. 4 Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period [DOI]
  5. 5 Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis [DOI]
  6. 6 Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting [DOI]
  7. 7 Hepatitis B virus and human immunodeficiency virus co‐infection in sub‐Saharan Africa: a call for further investigation [DOI]
  8. 8 Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Epidemiology, Natural History, and Treatment [DOI]
  9. 9 Toxoplasma gondii, HCV, and HBV seroprevalence and co‐infection among HIV‐positive and ‐negative pregnant women in Burkina Faso [DOI]
  10. 10 Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection [DOI]
  11. 11 Seroprevalence of hepatitis B and C viruses among HIV‐infected pregnant women in Uganda and Rwanda [DOI]
  12. 12 Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali.
  13. 13 Natural history of hepatitis B virus infection: pediatric perspective [DOI]
  14. 14 Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis [DOI]
  15. 15 Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia.
  16. 16 HBV/HIV co-infection: The dynamics of HBV in South African patients with AIDS [DOI]
  17. 17 The Prevalence and Risk Factors for Hepatitis B Surface Ag Positivity in Pregnant Women in Eastern Region of Ghana [DOI]
  18. 18 Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients [DOI]
  19. 19 Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan.
  20. 20 Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso [DOI]
  21. 21 Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing [DOI]
  22. 22 Hepatitis B Virus and HIV Infection [DOI]
  23. 23 A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection [DOI]
  24. 24 Prevention and management of drug resistant hepatitis B virus infections [DOI]
  25. 25 HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa [DOI]
  26. 26 Detection and prevalence of Hepatitis B and C among the residents of Umuaka Community, Njaba L.G.A, Imo State, Nigeria [DOI]
  27. 27 [Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso].

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

67

Page views

0

PDF downloads

20

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.